SHELBY JOHNSON: Open Payments
NPI 1750900098 · HARLAN, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,498 in 71 payments from 17 companies in 2025. Trend: 2023 $866 · 2024 $1,375 · 2025 $1,498
Food & beverage: $1,296Education: $203
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $290 |
| Otsuka America Pharmaceutical, Inc. | 13 | $226 |
| Alkermes, Inc. | 12 | $189 |
| Lundbeck LLC | 5 | $106 |
| Vanda Pharmaceuticals Inc. | 3 | $96 |
| Neurocrine BioSciences, Inc. | 5 | $94 |
| ABBVIE INC. | 4 | $77 |
| Almatica Pharma LLC | 4 | $74 |
| Corium, LLC | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
Products named: REXULTI, ARISTADA, FANAPT, INGREZZA, VRAYLAR, LOREEV XR, UZEDY, Azstarys.
Industry payments across IA — which companies pay providers there.
